Did You Know...
...that on Dec. 15, 1836, the Patent Office was completely destroyed by fire? Lost were some 7,000 models, 9,000 drawings, and 230 books plus all records of patent applications and grants.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110044901 | NOVEL COMPOUNDS The present invention is directed to sulphated compounds comprising at least one glycosidic amine group, and polysaccharide, oligosaccharide, peptide and protein derivatives comprising such compounds, and mixtures thereof. The present invention is also directed to metho... | 02/24/2011 |
| 20110041589 | NEW HPCL METHOD The present invention relates to new HPLC methods for the analysis of the drug substance clopidogrel and related substances. In a first method the mobile phase comprises two or more liquids, and the relative concentration of the liquids is varied to a predetermined grad... | 02/24/2011 |
| 20110039937 | NOVEL PROCESS FOR THE PREPARATION OF VORINOSTAT The present invention relates to an improved process for the preparation of the active pharmaceutical ingredient, vorinostat. In particular it relates to an efficient process for the preparation of vorinostat of high purity without the requirement to isolate any synthet... | 02/17/2011 |
| 20110034415 | WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS The invention describes to walnut oil extracts that have increased amounts of enriched in phospholipids, especially phosphatidylethanolamine (PE), phosphatidylcholine (PC), and phosphatidylinositol (PI) relative to walnut oil found in naturally occurring walnuts. It has... | 02/10/2011 |
| 20110032956 | WIDE TEMPERATURE RANGE (WiTR) OPERATING WAVELENGTH-NARROWED SEMICONDUCTOR LASER The present invention provides a wide temperature range (WiTR) operating wavelength-narrowed and wavelength-stabilized semiconductor laser having a wide bandwidth gain medium imbedded in a waveguide layer comprising a plurality of quantum dots or quantum wells wherein e... | 02/10/2011 |
| 20110028508 | NOVEL PROCESS FOR THE PREPARATION OF SCOPINE ESTERS The present invention relates to novel processes for the preparation of scopine esters and their quaternary salts. In particular, the present invention relates to a process for the preparation of tiotropium bromide, pharmaceutical compositions comprising tiotropium brom... | 02/03/2011 |
| 20110020439 | DELAYED RELEASE COMPOSITIONS OF DULOXETINE A delayed release dosage form comprising core comprising duloxetine or its pharmaceutically acceptable salts or derivatives thereof, optionally, other pharmaceutically acceptable excipient(s) thereof; intermediate layer; and enteric layer; wherein the dosage form compri... | 01/27/2011 |
| 20110020244 | PHARMACEUTICAL COMPOSITIONS The present invention relates to pharmaceutical compositions and in particular to suspension aerosol pharmaceutical compositions, processes to obtain them and their use in inhalation therapy.... | 01/27/2011 |
| 20110005960 | STABLE PHARMACEUTICAL COMPOSITIONS OF CARVEDILOL A stable solid oral pharmaceutical composition comprising carvedilol or a pharmaceutically acceptable salt thereof, which is packed using a suitable packaging material along with a desiccant. A process for manufacturing a stable solid oral dosage form containing carvedi... | 01/13/2011 |
| 20100331352 | NOVEL CRYSTALLINE FORMS OF BOSENTAN The present invention relates to novel crystalline forms of bosentan and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said crystalline forms and use of said compositions in the treatment of patients suffering ... | 12/30/2010 |
| 20100325053 | SYSTEM AND METHOD FOR NEW EXECUTION AND MANAGEMENT OF FINANCIAL AND DATA TRANSACTIONS A system and method for execution of financial and data transactions includes a point-of-sale device configured to execute a transaction in which at least one good or service is sold to an individual having a card with a storage medium encoding a card number. The transa... | 12/23/2010 |
| 20100324139 | PROCESS TO PREGABALIN The present invention relates to a novel method for the preparation of racemic pregabalin (1) or a single enantiomer thereof, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2). ... | 12/23/2010 |
| 20100316782 | PROCESS FOR REBAUDIOSIDE D The invention describes compositions that include rebaudioside D, processes to produce rebaudioside D and formulations that provide ratios of rebaudioside A to rebaudioside D to decrease the aftertaste of rebaudioside A.... | 12/16/2010 |
| 20100305347 | PROCESS FOR SEPARATING SATURATED AND UNSATURATED FATTY ACIDS A process for separating a blend of saturated and unsaturated fatty acids or saturated and unsaturated fatty acid alky esters into a first fraction enriched with the saturated fatty acids or saturated fatty acid alkyl esters and a second fraction enriched with unsaturat... | 12/02/2010 |
| 20100292290 | NOVEL PROCESS TO PREPARE ALMOTRIPTAN The present invention relates to a novel process for the preparation of almotriptan and pharmaceutically acceptable salts thereof, which affords product conveniently and efficiently with commercially acceptable yields and purity. The present invention also relates to a ... | 11/18/2010 |
| 20100288022 | NOVEL CHROMATOGRAPHY METHODS The present invention relates to novel HPLC methods for the analysis of the API formoterol and related substances. In a first method the mobile phase comprises two or more liquids, and the relative concentration of the liquids is varied to a predetermined gradient. In a... | 11/18/2010 |
| 20100280910 | SYSTEM AND METHOD FOR DISPUTING INDIVIDUAL ITEMS THAT ARE THE SUBJECT OF A TRANSACTION A system and method for disputing individual items that are the subject of a transaction includes storing, in a database, a record of a transaction in which a plurality of goods or services were sold to an individual that owns a transaction card through which access to ... | 11/04/2010 |
| 20100280893 | SYSTEM AND METHOD FOR IMMEDIATE ISSUANCE OF TRANSACTION CARDS A system and method for substantially immediate issuance of transaction cards includes at least one unassigned transaction card including a storage medium having a card number encoded thereupon. The system also includes a computing system configured to receive applicati... | 11/04/2010 |
| 20100274012 | Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer The invention describes novel crosslinking compounds that include photoactivatable moieties. Several families of compounds are disclosed that can include one or more hydrophilic moieties that help to solubilize the compounds in aqueous environments.... | 10/28/2010 |
| 20100261742 | NOVEL POLYMORPHIC FORMS Novel polymorphic forms of bosentan and processes for their preparation are disclosed. Further, pharmaceutical compositions comprising said polymorphic forms and the use of said compositions in the treatment of patients suffering from endothelin receptor mediated disord... | 10/14/2010 |
| 20100257654 | BREATHABLE GARMENT AND METHOD OF USE A garment includes a front side and a back side. The front side and back side are coupled to surround at least part of a person's body. The front side includes a mesh outer shell and a lightweight inner mesh liner, and the inner mesh liner includes a material that provi... | 10/14/2010 |
| 20100256208 | NOVEL PROCESS The present invention relates to a novel process for the preparation of rizatriptan and its pharmaceutically acceptable salts. It provides a novel process for the preparation of highly pure rizatriptan, which can be easily adopted for commercial production with a high d... | 10/07/2010 |
| 20100256207 | AMORPHOUS OLMESARTAN MEDOXOMIL The present invention is directed towards amorphous olmesartan medoxomil, to methods for preparing the compound, to compositions comprising the compound, and to the use of said compound and compositions for the treatment or prevention of an angiotensin II receptor media... | 10/07/2010 |
| 20100256206 | CRYSTALLINE FORM B OF OLMESARTAN MEDOXOMIL The present invention is directed towards a novel crystalline form of olmesartan medoxomil, to methods for preparing the compound, to compositions comprising the compound, and to the use of said compound and compositions for the treatment or prevention of an angiotensin... | 10/07/2010 |
| 20100234590 | PROCESS FOR THE PURIFICATION NE OF OLANZAPINE The present invention relates to a novel process for the preparation of pharmaceutically pure olanzapine. The invention is also related to impurities obtained during the preparation of pharmaceutically pure olanzapine and methods for the detection of the impurities.... | 09/16/2010 |
| 20100234468 | NOVEL PROCESS The present invention relates to a process for the preparation of polymorphic forms of the R- and S-enantiomers of modafinil, R-(−)-2-benzhydrylsulfinylacetamide and S-(+)-2-benzhydrylsulfinylacetamide respectively.... | 09/16/2010 |
| 20100222451 | THREE PART DENTAL BONDING COMPOSITIONS AND METHODS OF USE Three part bonding compositions that include an etching solution, a preparative solution, and a curable composition, as well as packaged products and methods of use for the treatment of bone substrate, i.e., teeth, are described. The etch solutions generally include an ... | 09/02/2010 |
| 20100216882 | ASPIRIN-TRIGGERED LIPID MEDIATORS Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with diseases, including ischemia.... | 08/26/2010 |
| 20100210572 | HYDROLYSATE OF CROCIN The present invention relates to a composition derived from the hydrolysate of plant containing crocin or the derivatives thereof. The composition includes a significant amount of crocetin monoester. The present invention also provides a method to hydrolyze crocin exist... | 08/19/2010 |
| 20100196858 | SILANOL BASED DENTAL TREATMENT Etching compositions, curable compositions, packaged products and methods of use for the treatment of bone substrate, i.e., teeth, are described. The etch solutions generally include an aqueous acidic solution with an ethylenically unsaturated monomer and a silane. The ... | 08/05/2010 |
| 20100137646 | PROCESS FOR THE PREPARATION OF XANTHOPHYLL CRYSTALS The invention describes the preparation and isolation of xanthophylls from plant sources. whereby a transesterification process is utilized without the necessity of an aqueous format.... | 06/03/2010 |
| 20100107338 | CRIB SHIELD SYSTEM AND OTHER BREATHABLE APPARATUS An apparatus and method for making same utilizing a breathable mesh material having a reduced suffocation resistance level for infant and toddler use. The breathable mesh material includes an inner and outer fabric that includes larger openings on the front substructure... | 05/06/2010 |
| 20100105772 | USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS The present invention is generally drawn to novel isolated therapeutic agents, termed lipoxins, generated from the interaction between a dietary omega-6 polyunsaturated fatty acid (PUFA) such as arachidonic acid (AA), oxygenases and the analgesic aspirin (ASA). Surprisi... | 04/29/2010 |
| 20100081750 | Nanotextured Surfaces The invention describes novel compositions that include a cross linking compound, a polymer and a 1 nm to about a 25 micron sized particle optionally with an oxide layer. In particular, the particle is a silica and one which has been pretreated with a silane.... | 04/01/2010 |
| 20100076086 | PROCESS FOR THE PREPARATION OF O-DESMETHYL VENLAFAXINE The present invention relates to a novel process for the preparation of O-desmethyl venlafaxine (ODV).... | 03/25/2010 |
| 20100063160 | POLYMORPHS OF O-DESMETHYL VENLAFAXINE SUCCINATE The present invention relates to crystalline forms of O-desmethyl venlafaxine (ODV) succinate monohydrate, namely Forms I and II, in pure form and to novel processes for their preparation. The present invention provides a process for the preparation of Form II free of F... | 03/11/2010 |
| 20100048702 | PREVENTION OF NEUTROPHIL RECRUITMENT Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.... | 02/25/2010 |
| 20100035994 | NOVEL HYDRATE FORM OF O-DESMETHYL VENLAFAXINE SUCCINATE The present invention relates to a novel hydrate form of O-desmethyl venlafaxine succinate. The present invention further relates to processes for the preparation of the novel hydrate form, pharmaceutical compositions comprising it, second medical uses of the novel hydr... | 02/11/2010 |
| 20100028474 | SESAME SEED DERIVED PIGMENTS The invention describes reduced sesame seed derived pigments and methods to prepare such pigments.... | 02/04/2010 |
| 20100021969 | EXTRACTION OF PHYTOCHEMICALS BY ENZYMATIC HYDROLYSIS A process for extracting phytochemicals from plants. The process generally comprises controllably slurrying a selected plant material in a volume, adding a selected enzyme the slurry while it is controllably agitated, then heating the controllably agitated slurry-enzyme... | 01/28/2010 |
